INTRODUCTION {#SEC1}
============

Pathways are biological network models defining how biomolecules cooperate to accomplish cellular tasks in different contexts. Pathways are assembled from physically-interacting molecules such as proteins and thus, to obtain a comprehensive image of pathways, we need to know all their participating physical components and the physical interactions among them. In addition, we need to know the context, i.e. tissue or disease, where such interactions and pathways are physiologically meaningful. Despite the advances and the amount of important information available in human pathway databases, and their critical role in bioinformatics workflows and systems-biology research, at the present time, they are still far from being complete.

To increase coverage of human pathway databases and improve results of pathway-enrichment analysis, we have developed [path]{.ul}way [D]{.ul}ata [I]{.ul}ntegration [P]{.ul}ortal, pathDIP ([@B1]). Through integration of data available in 22 widely used human pathway databases and physical protein--protein interaction (PPI) networks obtained from IID ([@B2]) we increased coverage of pathway annotations for human proteins, improved consistency in coverage of individual pathway sources for proteins, predicted pathway annotations for thousands of proteins with no annotation in curated pathway databases (i.e. pathway orphans), and provided annotations on physical connections among each protein and protein members of each pathway. While pathways available in the source databases, i.e. *core* pathways, annotate 65% of the human proteome, combining them with our network-based predictions, i.e. *extended* pathways, increases this coverage to 92%. Moreover, leave-one-out cross-validation shows that our predictions recover 87% of *core* pathway members.

Shortcomings of literature-curated human pathway databases affect non-human organisms even more. It is important to address these caveats, since non-human organisms are widely-used during validation experiments and to find answers to diverse questions such as understanding evolution, discovering molecular mechanisms in cells, studying diseases and developing drugs. Therefore, understanding species-specific molecular networks and pathways can directly and indirectly affect these areas.

At the present time, only a handful of sources, such as BioCyc database collection ([@B3])---including but not limited to MouseCyc ([@B4]) and YeastCyc ([@B5]), in addition to HumanCyc ([@B6]), and 54 other organisms (Tier 1 and 2 Pathway/Genome Databases (PGDBs)), ConsensusPathDB ([@B7]), KEGG ([@B8]), Panther ([@B9]), Reactome ([@B10]) and WikiPathways ([@B11]) provide pathway annotations for non-human organisms. However, most non-human pathway annotations in ConsensusPathDB, KEGG, Panther, Reactome and WikiPathways are predictions using orthologs of human proteins, leaving only limited sets of literature-curated pathways covering a small fraction of non-human proteins. Importantly, identifying literature-curated and *ortholog* pathways in these sources is often difficult or impossible. Several non-human organisms in pathDIP 4 have two or three source databases, including chicken, cow, fly, mouse, rat, worm and yeast. Mouse and yeast have the largest number of pathways with 495 and 458 pathways, and 4353 and 1196 annotated proteins, respectively (Table [1](#tbl1){ref-type="table"}).

###### 

Coverage of different annotation sets (*core*, *ortholog* and *extended* pathways) for unique proteins and the number of pathways per annotation set across different species, as well as the number and ratio of proteins annotated only through network-based predictions

  ---------------------
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In pathDIP 4, we focused on improving annotations and analysis services for human proteins and sixteen non-human organisms (cat, chicken, cow, dog, duck, fly, guinea-pig, horse, mouse, pig, rabbit, rat, sheep, turkey, worm and yeast). We approached caveats due to lack of available resources and annotations, low coverage for species-specific proteins, and missing physical connectivity among pathway proteins in non-human organisms through our well-established network-based algorithm ([@B1]) and ortholog-based consensus method.

PathDIP 4 provides pathway annotations for six model and ten domesticated organisms (Table [1](#tbl1){ref-type="table"}). We annotated proteins with 6401 pathways (total across all species) by: (i) *core* pathways, i.e. pathways from literature-curated databases, (ii) *ortholog* pathways, i.e. pathway annotations using protein orthologs in human and (iii) *extended* pathways, i.e. integration of species-specific PPIs with pathways of the first two sets to obtain species-specific network-based predictions and combining them with *core* and *ortholog* pathways. Our predictions extend coverage of pathways for proteins from 23 771 to 120 621 across seventeen species, including human.

Human pathway annotations include the most up-to-date versions of human databases, and two new sources (ACSN2 ([@B12]) and Panther ([@B9])) and cover 13,088 proteins in *core* and 18 454 proteins in *extended* pathways. Furthermore, we have extended functionality of pathDIP 4 in several ways, including services such as pathway source grouping, search pathways, miRNA-target search and JAVA, Python and R APIs.

In this paper, we describe extensions of data and services available through pathDIP 4 (<http://ophid.utoronto.ca/pathDIP>), and provide examples on how these improvements can help in approaching some important research problems.

MATERIALS AND METHODS {#SEC2}
=====================

Data collection and processing {#SEC2-1}
------------------------------

### Core pathways for human {#SEC2-1-1}

We obtained protein members of 5380 pathways from 22 pathway databases ([Supplementary Table S1A](#sup1){ref-type="supplementary-material"}): ASCN2 ([@B12]), BioCarta ([@B13]), EHMN ([@B14]), HumanCyc ([@B6]), INOH ([@B15]), IPAVS ([@B16]), KEGG ([@B17]), NetPath ([@B18]), OntoCancro ([@B19]), Panther ([@B9]), PharmGKB ([@B20]), PID ([@B21]), RB-pathways ([@B22]), Reactome ([@B10]), Signalink2.0 ([@B23]), SIGNOR2.0 ([@B24]), SMPDB ([@B25]), SPIKE ([@B26]), STKE ([@B27]), System-biology.org ([@B28]), UniProt Pathways (<https://www.uniprot.org/help/pathway>), WikiPathways ([@B11]). It is worth mentioning that although KEGG uses computational methods to reconstruct human-specific pathways from KEGG maps, the maps they use are extracted from the experimental knowledge available in the literature.

### Core pathways for model and domesticated organisms {#SEC2-1-2}

We downloaded and pre-processed pathways for seven model and domesticated organisms (chicken, cow, fly, mouse, rat, worm and yeast) from five sources (MouseCyc ([@B4]), Panther, Reactome, WikiPathways and YeastCyc ([@B5])) ([Supplementary Table S1B](#sup1){ref-type="supplementary-material"}). From any source that combines literature-curated and *ortholog* pathways to human, we removed *ortholog* pathways. We did not include KEGG in the sources of non-human pathways as it reconstructs species-specific *pathways* from KEGG *maps* through computational methods that partly use protein ortholog information, which is also used in pathDIP 4.

### Protein IDs, orthologs and interactions {#SEC2-1-3}

We downloaded 1:1 orthologs from Ensembl ([@B29]) release 92. Mappings between UniProt ID, NCBI Gene ID and protein names are based on UniProt ID conversion service (as of May 2019). Species-specific PPI networks of human and sixteen non-human species were obtained from IID ([@B2]) (version 2018--11) ([Supplementary Table S1C](#sup1){ref-type="supplementary-material"}).

### Disease proteins {#SEC2-1-4}

We obtained a list of 691 proteins associated with psoriasis and 304 proteins associated with osteoarthritis from DisGeNET (<http://www.disgenet.org>, August 2019) ([@B30]). For osteoarthritis, human proteins were mapped to their 1:1 orthologs for each of the other 16 species (DisGeNET only includes human genes), while for psoriasis the mapping was done only to mouse as mouse models are the most frequently used animal models in psoriasis studies ([@B31]). Human proteins that had no orthologs in any other species were discarded. Each list of proteins was used to query pathDIP 4 in its relevant species. In human only, we had two sets of *extended* pathways, one through only experimentally detected PPIs and one through all PPIs (i.e. combination of experimentally detected and computationally predicted). For psoriasis, we used these two sets (both at 0.99 confidence level), in addition to the *core* pathways. For osteoarthritis, we used *core* and *ortholog* pathways.

Pathway member prediction {#SEC2-2}
-------------------------

### Predictions based on orthology {#SEC2-2-1}

For each non-human organism, we replaced members of *core* human pathways with their orthologs and kept only pathways with at least three ortholog members (i.e. we did not consider a single protein or a single interaction (two proteins) as a pathway) ([Supplementary Table S1D](#sup1){ref-type="supplementary-material"}).

### Predictions based on physical network connectivity {#SEC2-2-2}

For all seventeen species in pathDIP 4, we used species-specific PPI networks (obtained from IID) to predict statistically significant protein-pathway associations as described in ([@B1]). For human, we provide predictions using *core* pathways and two sets of PPIs: (i) experimentally detected PPIs, and (ii) the full set of human PPIs available in IID (i.e. the combination of experimentally detected and computationally predicted with high confidence). For non-human species, we used only one set of PPIs, i.e. the full set of species-specific PPIs, to predict strong physical associations between each protein and each pathway in *core* (if available) or *ortholog* pathway sets.

#### Calculation of recovery rate for human {#SEC2-2-2-1}

We divided the number of protein-pathway pairs annotated both as 'Known' (experimentally detected and available in the literature) and 'Pred' (network-based predictions) by the number of protein-pathway pairs in the *core* pathways table whose protein is present in human PPI network (experimental only or experimental and predicted).

#### Procedure to compare recovery between ortholog pathways and network-based predictions {#SEC2-2-2-2}

We used three sets of species-specific protein-pathway pairs for these comparisons:A subset of *core* pathways whose titles have exact matches in human and protein members that are available in the species-specific PPI network;*Ortholog* pathways;Predictions based on only *core* pathways (i.e., predictions based on *ortholog* pathways were not considered) and species-specific PPI networks.

Next, in each organism, we compared the overlap of protein-pathway pairs in set 1 with protein-pathway pairs in sets 2 and 3.

#### Procedure to compare conservation of DNA replication pathway across different species {#SEC2-2-2-3}

We focused on species with available *core* pathways (chicken, cow, fly, mouse, rat, worm, yeast). For these species, we collected proteins from *core*, *ortholog* and *extended* pathways whose titles include 'DNA replication'. We then looked at the number of *ortholog*s present from one species to the next closest in evolutionary terms.

#### Enrichment analysis {#SEC2-2-2-4}

We used Fisher\'s Exact test followed by correction for multiple hypothesis testing by two different methods, Bonferroni and False Discovery Rate to calculate enrichment of input at two levels of pathways and pathway titles as explained in ([@B1]).

#### Word clouds {#SEC2-2-2-5}

Term enrichment was performed as above, and word clouds were generated using Wordle (<http://www.wordle.net>).

#### Jaccard Index {#SEC2-2-2-6}

Jaccard Index is the result of dividing the size of overlap by the size of union of any two sets of pathways and was performed in R 3.6.0.

PORTAL DESCRIPTION {#SEC3}
==================

Data {#SEC3-1}
----

PathDIP 4 annotates 120 621 protein-coding genes to 6401 pathways across human and 16 non-human organisms (Table [1](#tbl1){ref-type="table"}). Only 23 771 of these genes have *core* pathway annotations, thus, pathDIP 4 provides novel pathway annotations for 96 850 pathway-orphan genes. Importantly, 36 216 genes are annotated only through network-based pathway association predictions.

Functionalities {#SEC3-2}
---------------

We have substantially expanded pathDIP 4 services and functionalities. Novel pathDIP 4 features include categorization of pathway sources, search using miRNA targets, search using pathway terms, and pathDIP APIs. Here we describe all previous and novel features in pathDIP 4.

### Search genes tab {#SEC3-2-1}

#### Input and settings {#SEC3-2-1-1}

One of the novel features in pathDIP 4 is that users can select the species of interest and input pathDIP 4 with a list of proteins or genes specific to that species. Input list can contain UniProt ID, NCBI Entrez Gene ID or protein names. While pathDIP 4 input list is not case-sensitive, it returns case-sensitive protein names which is important in model organisms. Users can also select any subset of pathway source databases, as well as one of the listed annotations sets for each species, i.e. *core*, *ortholog* or *extended* (by predictions at different confidence cut-offs) pathways.

#### Enrichment analysis {#SEC3-2-1-2}

PathDIP 4 performs enrichment analysis at two different levels, pathways and pathway key-terms (words and expressions). To calculate the enrichment score, pathDIP 4 uses the Fisher\'s Exact Test, followed by correction for multiple hypothesis testing by two different methods, Bonferroni and False Discovery Rate.- *Pathway-enrichment analysis*: uses the input list and the selected annotation sets to find the pathways significantly enriched with proteins or genes in the input list.- *Term-enrichment analysis*: uses biologically informative terms in enriched pathway titles to find which terms are significantly over-represented in enriched pathway titles. To extract the set of terms, we first defined a set of 393 rules to remove non-informative words and unnecessary characters and define multi-word terms (e.g. cell-cycle). Next, we cleaned this list through manual curation.

This service helps summarize and visualize pathway-enrichment results, and is particularly helpful when result lists from pathway-enrichment analyses contain hundreds of pathways.

#### Color-coding of pathway source databases {#SEC3-2-1-3}

We have grouped pathway databases according to their content into six categories ([@B32]): metabolic, drugs and small molecules, signaling and regulatory, genome maintenance, general and cancer pathway databases (Table [2](#tbl2){ref-type="table"}). It helps users to select subsets of pathway databases suitable for their study.

###### 

Classification of pathway source databases according to their context-specificity, and their colour-coding in pathDIP 4. This categorization facilitates selecting pathway databases in the context that is most suitable to each study

  ---------------------
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### Search miRNAs tab {#SEC3-2-3}

PathDIP 4 provides users a pipeline through integration of mirDIP ([@B33]), a miRNA--target database, and pathDIP 4, to perform pathway annotation and enrichment analysis of miRNA targets in one step. Instead of querying mirDIP first, taking its output and putting it in pathDIP 4 input format, users can input a list of miRNA IDs and select the level of confidence for miRNA--target pairs ([@B33]). Next, they select pathway sources and annotation set. pathDIP 4 first sends the input list of miRNA IDs and confidence settings to mirDIP and receives the list of miRNA--targets. Next, it uses the list of target proteins to perform pathway annotation and analysis using parameters set for pathways. The output contains annotation and enrichment analysis results for the list of miRNA targets. This service is available only for human as mirDIP is a human-specific miRNA--target database.

### Search pathways tab {#SEC3-2-4}

Through this tab, users can perform annotation and enrichment analysis of any subset of pathways (not limited to a particular database). This service, which is new to pathDIP 4, uses the table of terms explained above (see term enrichment analysis) and enables users to select the list of pathways most suitable to their study.

PathDIP 4 provides two approaches to input search keywords. The first approach is to use a list of characters provided in Search Pathway tab. Upon clicking on each character, a list of pathway title keywords starting with that character appears. Users can click on any of the keywords to add it to the list of pathways of their interest. The second option is to use a drop-down search box. Users can type any part of a keyword. If any keyword including the typed character is available in pathDIP 4, a drop-down list containing those keywords appears that allows users to select the full keyword.

After selecting the keywords and databases of interest, users can search and receive a list of pathway titles including those keywords. PathDIP 4 allows users to review and refine this list of pathways. Next, they input a list of protein/gene IDs and select one of the pathways sets for further annotation and enrichment analysis only across their selected pathways. If user selects 'save as tab delimited' instead of 'search', a file containing input genes annotated with pathways including the selected words will be downloaded.

### API {#SEC3-2-5}

PathDIP 4 provides Java, Python and R APIs to facilitate programmatic use of pathway annotation and enrichment analysis.

RESULTS AND DISCUSSION {#SEC4}
======================

PathDIP 4 content {#SEC4-1}
-----------------

PathDIP 4 annotates 120 621 proteins with 6401 pathways across seventeen organisms, in three pathway tables.

### Core pathways {#SEC4-1-1}

*Core* pathways integrate literature-curated pathways available in 24 pathway databases and annotate 23 771 proteins in eight species (human: 13 088, chicken: 390, cow: 857, fly:935, mouse: 4353, rat: 1597, worm: 1355, yeast: 1196) (Table [1](#tbl1){ref-type="table"}). However, while twenty-two of these resources focus on human, we found only five sources with literature-curated pathways for non-human organisms and the number of these pathways remains limited ([Supplementary Table S1B](#sup1){ref-type="supplementary-material"}).

### Ortholog pathways {#SEC4-1-2}

*Ortholog* pathways are predictions based on direct mapping of human *core* pathway members to their ortholog proteins in other organisms ([Supplementary Table S1D](#sup1){ref-type="supplementary-material"}). In PathDIP 4, 68 035 proteins across 16 species are annotated to *ortholog* pathways. Although this approach improves the coverage of pathway annotation for non-human organisms, the annotations are bound to the limitations of *core* human pathways, i.e. high rate of pathway orphans and low overlap across different source databases. In addition, only fractions of the proteins in these organisms have orthologs available in human.

Figure [1A](#F1){ref-type="fig"} shows the distribution of conservation of pathways across organisms. The least conserved pathways (conserved in no or one organism) are enriched in terms 'defective' and 'biosynthesis' while the pathways conserved in all organisms are enriched in words 'signaling', 'degradation', 'RNA', 'transcription', 'response', 'wnt', 'APC-C', 'mitotic', 'Cell-cycle', 'apoptosis', etc. The term 'metabolism' was over-represented in both groups ([Supplementary Table S2A](#sup1){ref-type="supplementary-material"}).

![(**A**) Distribution of the number of non-human organisms covered by each *ortholog* pathway. Pathways with count organism '16' are human pathways for which we provide *ortholog* pathways in all non-human organisms, while pathways with count organism '0' are human pathways with no *ortholog* pathways in pathDIP 4. (**B**) Recovery rate for *core* protein-pathway pairs through *ortholog* and network-based predictions. In chicken and cow, where almost all available PPIs used for network-based predictions are orthologous ones, networks do not improve recovery, whereas in fly, yeast and worm, in which experimental PPIs are more prevalent, networks improve recovery drastically. (**C**) Comparing coverage of the three largest pathway databases pathDIP 4 (*core*, *ortho*, *extended*), full Reactome (i.e. combination of *core* and *ortholog* pathways) and full WikiPathways for proteins across different species shows that *extended* pathways in pathDIP 4 annotate the largest number of proteins compared with the other two databases. The only two exceptions are chicken and pig. Among all 24 source databases, Reactome and WikiPathways provide the two largest number of *core* pathways in human (separately) and in non-human organisms (combined) (details in [Supplementary Tables S1A and B](#sup1){ref-type="supplementary-material"}). Plots generated using R package *ggplot2* (version 3.2.1).](gkz989fig1){#F1}

### Extended pathways {#SEC4-1-3}

Although predicting pathway annotations for non-human proteins through their human orthologs significantly improves coverage of pathways for non-human organisms, it is not sufficient due to caveats in human pathways and limitations of ortholog mapping.

*Extended* pathways combine *core* and *ortholog* pathways, with predictions based on significance of physical connectivity of each protein with members of each *core* or *ortholog* pathway. Association-prediction based on network properties of proteins and genes has been applied to different research questions in molecular and systems biology ([@B34]). Compared to other network-based measures, connectivity-significance has been shown to be one of the best predictors of association (for example, to a group of disease genes or pathways) ([@B39]). PathDIP 4 annotates 120 621 proteins in human and sixteen non-human organisms. Furthermore, despite its relatively conservative approach (compared with other available algorithms such as ([@B39])), *extended* pathways annotate 36 216 pathway orphan proteins in sixteen species, i.e., proteins with no pathway annotations available in *core* or *ortholog* pathways.

In human, *extended* pathways increase coverage of pathway annotations for proteins from 65% (13 088 proteins) to 92% (18 454 proteins) and cross-validation determined recovery rate of up-to 87% for *core* pathways (Table [3](#tbl3){ref-type="table"}).

###### 

Coverage and recovery rate of *core* pathways, *extended* pathways using only experimental PPIs, and *extended* pathways using full (combination of experimental and predicted) PPIs for human proteins (top row) and their pathway memberships (bottom row) in pathDIP 4.

  Human pathways                           Curated   Extended using experimental PPIs (0.95)   Extended using experimental and predicted PPIs (0.95)
  ---------------------------------------- --------- ----------------------------------------- -------------------------------------------------------
  **Coverage for protein-coding genes**    *65%*     *89%*                                     *92%*
  **Recovery for known pathway members**   *-*       *59%*                                     *87%*

*Extended* pathways are based on 95% confidence cut-off.

Comparison of *ortholog versus extended* pathways {#SEC4-2}
-------------------------------------------------

### Coverage for proteins {#SEC4-2-1}

Comparing coverage of *ortholog* versus network-based predicted pathways for proteins shows that in all seventeen species combined, almost 30% of *extended* pathways are pathway orphans in *core* and *ortholog* pathways and have obtained their annotations through only network-based predictions (Table [1](#tbl1){ref-type="table"}). Across non-human species, network-based-only predictions cover between ∼0.2% (guinea-pig) and 70% (yeast) of *extended* pathways with median 27%. This highlights the importance of network-based predictions, even though in many organisms all network-based predictions are based on connectivity of proteins with only *ortholog* pathways and through only orthologous PPIs (due to lack of available experimental data).

### Recovery for core pathways {#SEC4-2-2}

To compare the recovery rate of ortholog-based versus network-based predictions, we focused on the seven organisms for which both *core* and *ortholog* pathways are available, i.e. chicken, cow, fly, mouse, rat, worm and yeast. Details are provided in 'methods' section and ([Supplementary Table S2B](#sup1){ref-type="supplementary-material"}).

Figure [1B](#F1){ref-type="fig"} shows recovery rate of *ortholog* pathways versus network-based pathways. Importantly, network-based predictions improve recovery of *ortholog* pathways for *core* protein-pathway pairs differently across different species. While in chicken and cow, PPIs improve recovery rate only slightly (1.03, 1.06), in fly, worm and yeast, networks improve the recovery by a factor of 2.20, 1.41, 2.37. In mouse and rat, the improvements are 1.11 and 1.10, respectively. Our further investigation showed that in chicken and cow, \<0.5% of PPIs are experimentally detected; thus, the major source of PPIs are orthologous PPIs whose proteins are a subset of proteins we used for *ortholog* pathway predictions. Similarly, in mouse and rat, experimentally detected PPIs constitute 10 and 2.8% of the full network. However, in worm, fly and yeast, experimentally detected PPIs make ∼22%, ∼57% and 80% of the PPI network, respectively. A similar trend is observed for the number of proteins in experimental versus orthologous PPI networks ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"} and [Supplementary Tables S2C and D](#sup1){ref-type="supplementary-material"}). These numbers can explain the differences in recovery rates of *ortholog* versus network-based protein-pathway predictions across different species, and reinforce the importance of integration of data with different types of sources to extract relevant information. In fact, experimental PPIs, whose detection method is independent of ortholog proteins, improve recovery-rate markedly better than using only orthologous PPIs.

Comparison of pathDIP 4 with other databases {#SEC4-3}
--------------------------------------------

Comparison of *core, ortholog* and *extended* pathways in pathDIP 4 with the combination of literature-curated and ortholog pathways in Reactome and WikiPathways, the two largest publicly available databases for ortholog pathways in organisms, shows that coverage of pathDIP 4 for proteins in most of the organisms is higher than coverage of the other two databases (Figure [1C](#F1){ref-type="fig"}). For several organisms, the protein coverage of *ortholog* pathways in PathDIP 4 is lower than the coverage of ortholog pathways in Reactome (release 68). However, when the *extended* pathways are selected, the coverage of PathDIP 4 becomes higher than that of Reactome. Two exceptions are chicken and pig. Lower coverage of *ortholog* pathways in pathDIP 4 for proteins is due to using a more reliable set of orthologs (inclusion of only 1:1 orthologs) compared with Reactome. [Supplementary Figure S1B](#sup1){ref-type="supplementary-material"} compares the number of pathways available in different pathway sets in pathDIP 4, full Reactome and full WikiPathways per species.

While network-based predictions are specific to PathDIP 4, to the best of our knowledge, it is the only available integrated resource that provides direct distinction between *core* and *ortholog* pathways. In addition, direct miRNA--target pathway analysis, pathway source classification, and term-enrichment analysis are additional useful features specific to pathDIP 4.

Example applications {#SEC4-4}
--------------------

### Conservation of DNA replication pathway across different species {#SEC4-4-1}

To show the quality of our predictions across species, we looked at a pathway that is highly conserved: DNA replication ([@B40]). Figure [2A](#F2){ref-type="fig"} shows that proteins annotated only with *core* pathways are conserved among mammals or among lower organisms (fly, worm and yeast), while inclusion of orthologs and predicted pathway annotations extends the overlap from human to yeast. Interestingly, 14 genes present in the *ortholog* pathway set in cow have orthologs in the *core* pathways in fly (PRIM2, POLE, RPA1, RFC3, RFC5, MCM7, CDC45, ORC5, ORC2, CDC6, CDT1, MCM10, ORC4, ORC1), providing experimental support for the ortholog approach. When considering *core* and predicted pathway annotations for human, the overlap of DNA replication proteins between human and other seven species increases. 40 proteins (listed in [Supplementary Table S3A](#sup1){ref-type="supplementary-material"}) are present in all the species from human to yeast. Of these, 9 are present in yeast *core* pathways, 11 in yeast *ortholog* pathways and the remaining 20 in predicted pathways. Interestingly, all 20 are present only in predicted pathways in all the 7 species considered, even though among them there are proteins that have been described being involved in DNA replication (i.e. MRE11A ([@B41]), XPO1 ([@B42]), SMC2 ([@B43])). Of note, three proteins annotated with predicted DNA replication pathways in human have orthologs in other species that are annotated with *core* pathways (HIST1H3J, HIST2H3D and TOP1MT between human and mouse; HIST2H3D and TOP1MT between human and rat).

![(**A**) Conservation of DNA-replication pathways across multiple species. For DNA replication pathways in each species, orthologs to human were considered, and overlap of orthologs per consecutive pairs of species are shown. Each bar represents an organism and each color represents genes present in *ortholog* (bottom), expanded (middle) and *core* (top) DNA replication pathways. Flow among bars depicts the number of proteins with orthologs from the starting organism to the landing one. Flow color grows darker with the number of organisms in which a set of proteins is conserved. (**B**) Overlap among *core* pathways in different species after enrichment analysis using osteoarthritis genes or their orthologs. (**C**) Heatmap of Jaccard indices of pathways across different species. Human pathways were obtained using *core* pathways while for every other species only *ortholog* pathways were used. Plots generated based on R package *alluvial* (version 6.3.0) modified by authors, *UpSetR* (version 1.3.3), and *ggplot2* (version 3.1.0).](gkz989fig2){#F2}

### Ranking the non-human organisms suitable for disease-related functional genomics studies {#SEC4-4-2}

Osteoarthritis-associated genes were obtained from DisGeNET and their orthologs in other species were used to query pathDIP 4 using *core* pathways to observe disease-specific pathway conservation. Overlap of *core* pathways among the species with available *core* pathways is quite poor (Figure [2B](#F2){ref-type="fig"}), while the overlap notably improves among all species when we consider *ortholog* pathways (Figure [2C](#F2){ref-type="fig"} and [Supplementary Table S3B](#sup1){ref-type="supplementary-material"}). The three invertebrate species, fly, worm and yeast did not have any enriched pathway. Duck had only one enriched pathway, which was also present in all remaining twelve species and in human: Endochondral Ossification, a process essential for osteoarthritis development ([@B44]). A total of 76 pathways were present in 11 out of 14 vertebrates, and these included processes linked to osteoarthritis such as TGF-beta signaling ([@B45]), GPCRs ([@B46]) and inflammation ([@B47]), as visible in ([Supplementary Figures S2A and B](#sup1){ref-type="supplementary-material"}).

Interestingly, model organisms used to study osteoarthritis include mouse (Jaccard Index (JI) with human is 0.88), rat, guinea pig (JI for both: 0.63), dog (JI: 0.57), rabbit (JI: 0.53), horse (JI: 0.42) and sheep (JI: 0.23) ([@B48]). Our data suggest not studying molecular mechanisms of osteoarthritis parallel to human in sheep, whereas cow, as the second highly overlapping organism (after mouse, JI: 0.68), is a good candidate ([Supplementary Table S3C](#sup1){ref-type="supplementary-material"}). Cow has naturally occurring osteoarthritis ([@B49]) and has been previously proposed as a model organism for knee osteoarthritis due to the similarity of its knee to the human\'s ([@B50]). Cat, turkey and duck have very little overlap (JI: 0.3, 0.008 and 0.001, respectively) while pig and chicken have an intermediate overlap (JI: 0.47 and 0.46, respectively). Commercial pigs have been used as model organisms for naturally occurring osteoarthritis ([@B51]), even if their knee structure is less similar to the human one than cow ([@B50]), while chicken has been proposed in the past but never really used ([@B52]), to the best of our knowledge.

This analysis highlights the application of pathDIP 4 data in selecting the right model organism (even beyond the most commonly used ones if needed) for the type of molecular mechanism to be studied, especially when the aim is to translate any finding to human diseases and treatments.

### Psoriasis: network-based predictions extend the set of disease-related pathways {#SEC4-4-3}

We used the genes associated to psoriasis to obtain pathway-enrichment using human *core* and *extended* sets as described in 'Materials and Methods' section. We obtained 1148 pathways in *core* pathways, 1737 in *extended* using experimental PPIs and 2531 in *extended* using all PPIs (experimental and predicted) ([Supplementary Tables S3D and E](#sup1){ref-type="supplementary-material"}). A total of 972 such pathways were common among the three sets, and included pathways linked to MAPK and NFKB signaling and to immune processes ([Supplementary Figures S3A and B](#sup1){ref-type="supplementary-material"}). A total of 719 pathways were exclusively annotated as *extended* using experimental and predicted PPIs and included signaling and metabolism ([Supplementary Figure S3C](#sup1){ref-type="supplementary-material"}).

A total of 25 and 69 pathways were specific to the *core* and *extended* pathways respectively. Two psoriasis experts reviewed the two sets of pathways, aiming to verify whether they are linked to psoriasis. The two experts strongly disagreed on nine pathways (three from literature and six from *extended*), for a discordance rate of 9.5% ([Supplementary Tables S3F and G](#sup1){ref-type="supplementary-material"}). Sixteen pathways from the literature set were voted as related to psoriasis, five were 'maybe related' and one was considered unrelated. Of the *extended* set, 37 were labeled as related, 16 as 'maybe' or 'don't know' and 10 as non-related to psoriasis. Addition of the 37 psoriasis related pathways to the set of enriched pathways only through predicted pathways shows the importance of our predictions in performing comprehensive pathway analysis. Moreover, having only 10 non-related out of 69 *extended* pathways, along with 37 related and 16 gray zone ('maybe' or 'don't know') shows that the *extended* pathways mostly include pathways that are known to be or that can be meaningful to the proteins being analysed rather than only random pathways.

Psoriasis is a disease restricted to humans and it has been reported sporadically in few other animals, making it difficult to identify a proper model organism and translate findings from the model organism to human. At the present time, mouse models mimicking the disease are the most frequently used ([@B31]), so we queried mouse orthologs of human psoriasis related genes in mouse pathDIP 4, using *core*, *ortholog* and *extended* pathways. Twenty-seven pathways were enriched in *core*, 1129 in *ortholog* and 2534 in *extended* pathways. Thirteen pathways were present in all three sets, while two and 1075 were present in the overlap of *extended* pathways with either *core* or *ortholog* pathways (respectively) ([Supplementary Table S3H](#sup1){ref-type="supplementary-material"}). Term-enrichment performed on the union of these 1090 mouse pathways shows very similar terms when compared to 972 overlapping human pathways ([Supplementary Figure S4A and B](#sup1){ref-type="supplementary-material"}). This suggests conservation of molecular mechanisms of psoriasis in mouse and explains why mouse models have been successful even though mice do not spontaneously develop psoriasis.

SUMMARY AND CONCLUSION {#SEC5}
======================

PathDIP 4, compared with its previous versions, is substantially expanded and improved in several ways. In addition to human, it extends pathway annotations for sixteen non-human species through integrating different data types from several sources, provides new services such as pathway database classification and search pathways, as well as Java, Python and R APIs, and offers features specific to pathDIP 4 such as direct miRNA-target search for human and term enrichment analysis.

Limited coverage of *core* pathways for protein-coding genes of human and non-human organisms (Table [1](#tbl1){ref-type="table"}), along with the slow growth rate of *core* pathway annotations (57% in 2016 versus 65% in 2019 in human) demonstrates the importance of devising computational methods that use data integration to predict physically and biologically relevant protein-pathway associations. PathDIP 4 integrates *core* pathway data from 24 pathway databases (nineteen only for human, three for both human and organisms and two only for organisms). Limited coverage of literature-curated source databases affects pathDIP 4 too. Thus, we used two well-established prediction methods to improve coverage of pathway annotations for proteins, and improve consistency across data from different pathway sources. In pathDIP 4, *extended* pathways in human increase coverage for protein coding genes to 92%, while they extend protein coverage to 9.56 times for model organisms (Table [1](#tbl1){ref-type="table"}).

It is worth mentioning that despite all the improvements, pathDIP 4 annotations and analysis results are not free of errors and limitations in their sources. For example, in addition to their incompleteness and inconsistency, different data sources have been created for different purposes, cover different contexts and include different levels of detail. However, with the improvement of our source databases, coverage and quality of data in pathDIP 4 will improve, too. For example, while pathDIP 2.5 cross-validation in 2016 showed recovery rate for *core* pathways in human to be 71% ([@B1]), in pathDIP 4 recovery rate has increased to 87% (Table [3](#tbl3){ref-type="table"}).

Combined, our annotations cover 120 621 unique proteins in human, six model organisms, and ten domesticated animals, from which only 23 771 proteins have pathway annotations in the literature (for details see Table [1](#tbl1){ref-type="table"}). While in most of the organisms, network-based annotations overlap with high fraction of *ortholog* pathways (See 'comparison of *ortholog versus extended* pathways' section), 36 216 proteins are annotated only through network-based predictions, supporting the importance of data integration to extract present, but hidden information in different data sources and types.

Our three use-cases are only a few examples to highlight how improved coverage for proteins in multiple species provides a unique resource that enables comprehensive enrichment analysis, hypotheses generation, *in silico* validation and explanations in basic, translational and clinical research.
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###### 

Click here for additional data file.
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[Supplementary Data](https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkz989#supplementary-data) are available at NAR Online.
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